Recent

% | $
Quotes you view appear here for quick access.

Titan Pharmaceuticals Inc. Message Board

  • papaalien2000 papaalien2000 Dec 18, 2012 8:21 AM Flag

    chronic pain

    according to the cc the license deal is limited to Buprenorphine. Different active ingredients are not part of the deal. So TTNP is free to develop other drugs using the ProNeura technology in any indication they want. Obviously there is much room to use the ProNeura technology with a variety of pain killers. ProNeura has not been given away.

 
TTNP
6.01-0.05(-0.83%)Sep 23 4:00 PMEDT